A new furopyranone, phellifuropyranone A, was isolated from fruit bodies of wild Phellinus linteus as well as phelligridin G, and their chemical structures were determined by various spectroscopic methods including measurement of NMR spectra. Phellifuropyranone A together with meshimakobnol A and meshimakobnol B showed antiproliferative activity against mouse melanoma cells and human lung cancer cells in vitro.
Phellinus linteus (BERK. et CURT) Aoshima ("meshimakobu" in Japanese) is a Basidomycota fungus which has been reported to have anticancer activity derived from its polysaccharide constituents. 1, 2) In Japan, many kinds of dietary supplements containing P. linteus are available in the markets. These commercial products are prepared from either fruit bodies of the wild or cultivated mushrooms, the cultured mycelia or their mixtures and have been used for the same purpose irrespective of their origins. It may be possible that chemical constituents are different among P. linteus preparations produced from the different origins, which may lead to difference in pharmacological activities.
No report has described small molecule organic compounds in P. linteus and none has focused on the chemical difference among fruit bodies of the wild and cultivated mushrooms and the cultured mycelia. In a previous paper 3) we identified meshimakobnol A (1) and meshimakobnol B (2) for the first time from the fruit body of wild P. linteus ( Fig. 1) and suggested that these compounds may be used as indicative constituents for P. linteus product produced from the wild fruit body. In continuation of our investigation on low molecular weight components in P. linteus, we further isolated one new furanopyranone compound, phellifuropyranone A (3), together with one known compound phelligridin G (4) from the fruit body of wild P. linteus in addition to 1 and 2, and determined their chemical structures by mesurement of IR, UV, FT-MS, and 1D-and 2D-NMR spectra. Furthermore, the antiproliferative activities of phellifuropyranone A (3), meshimakobnol A (1) and meshimakobnol B (2) against mouse melanoma cells and human lung cancer cells were evaluated.
Results and Discussion
The compound 3 was obtained as dark yellow amorphous powder. The molecular formula of 3 was given as C 21 H 14 O 7 from the HR-ESI-FT-ICR MS spectrum (m/z 401.0632 [MϩNa] ϩ , Calcd for C 21 H 14 O 7 Na 401.0632). In the UV spectrum of 3, the absorption maxima were observed at l max 400 (log eϭ3.8) and 314 nm (3.6), which indicated long conjugation system. The IR spectrum of 3 showed the absorption bands at 1700 and 3418 cm Ϫ1 ascribable to carbonyl and hydroxyl, respectively. C-NMR spectrum were sp 2 carbons, and 10 of them were methine and the other 11 were quarternary carbons. The lowest carbon signal was that at d C 160.9 (C-7a), which suggested the presence of carbonyl group of the a-pyrone. For the next step, measurements of FG-HMQC and FG-HMBC were carried out. It was assumed that the two trisubstituted benzene rings were 3,4-dihydroxyphenyl groups from the correlation from H-4Ј to C-8Ј, H-7Ј to C-3Ј and C-5Ј to trans-olefine. The other 3,4-dihydroxyphenyl group was suggested to bind to olefine carbon combined with oxygen by HMBC correlations from the protons of H-2Љ and H-6Љ to C-2 (d C 157.0). The conjugation of the trans-olefine with pyrone ring was showed from the observations of HMBC correlations from one singlet proton of H-7 to the carbons of C-3a (d C 111.9), C-1Ј (d C 116.9), C-6 (d C 157.3) and C-7a, and from the olefine protons at H-1Ј and H-2Ј to C-6. The furo[3,2-c]pyran-4-one moiety combined with 3,4-dihydroxy phenyl group at C-2 was estimated by the observation of HMBC correlation from the other singlet proton of H-3 to C-2, C-3a and C-7a, and from the phenyl protons of H-6Љ and H-2Љ to C-2, and by the spectroscopic results mentioned above. The chemical shift value of H-3 was relatively lower field than that of usual furan, which suggested the effect of long conjugation and the influence from the carbonyl carbon of C-4 (d C 158.8). Although no HMBC correlations was observed from any protons to d C 158.8, the furopyranone ring structure of 3 was also supported by the chemical shifts of C-2, C-3a, C-4, C-6, C-7 and C-7a, which were in good agreement with the corresponding ones of other furopyranone compounds such as inoscavin C or methylinoscavin C.
4)
Thus, we determined the structure of the compound 3 as new compound, 2-(3,4-dihydroxyphenyl)-6-(2Ј-(3,4-dihydroxyphenyl)-E-ethenyl)-furo[3,2-c]pyran-4-one and named phellifuropyranone A. Phellifuropyranone A (3) has 6-(3,4-dihydroxystyryl)pyrone part, which is supposed to be derived from 6-(3,4-dihydroxystyryl)-4-hydroxypyrone (hispidin). As hypholomine B, 5) inoscavin A, 6) and inoscavin B 7) isolated from various mushrooms also have the same partial structure, phellifuropyranone A (3) and these compounds might give some information to consider biosynthetic pathway of furopyranone compounds from hispidin in several mushrooms.
Phelligridin G (4) was identified by measurements of 1 H-NMR spectrum and other spectra including 13 C-NMR and comparison of the spectral data (data not shown) with those reported previously.
8) The absolute configuration of 4 has not been determined yet and now under investigation.
The antiproliferative activities of phellifuropyranone A (3), in addition to meshimakobnol A (1) and meshimakobnol B (2) against five kinds of B16 cell lines and three kinds of human lung cancer cell lines A549, EBC-1 and SBC-3 were evaluated. 9, 10) As shown in Table 2 , phellifuropyranone A (3) suppressed the proliferation of mouse melanoma and human lung cancer cell lines with a 50% growth-inhibitory concentration (GI 50 ) of 5.6-31.3 mM. Meshimakobnol A (1) suppressed them with GI 50 of 7.1-22.6 mM, and meshimakobnol B (2) also did with GI 50 of 6.1-15.0 mM. These results showed that the antiproliferative activities of phellifuropyranone A (3), meshimakobnol A (1) and meshimakobnol B (2) were almost the same.
Conclusion
We isolated a new furopyranone compound named phellifuropyranone A (3) together with phelligridin G (4), meshimakobnol A (1) and meshimakobnol B (2) from fruit bodies of wild grown P. linteus. Though phellifuropyranone A (3) was obtained in much lower yield than meshimakobnol A (1), the phellifuropyranone A (3) may be used as an indicator compound to discriminate the wild plant-derived preparations of P. linteus from the cultivated plant-derived and cultured mycelia-derived preparations. HPLC analysis of the various P. linteus plants and commercially available prepara- Antiproliferative activity of 1-3 and paclitaxel (positive control) were determined as described in Materials and Methods. GI 50 values are represented as mM. Jϭ8 Hz).
tions is now under investigation. Phellifuropyranone A (3) together with meshimakobnol A (1) and meshimakobnol B (2) showed low antiproliferative activity compared with paclitaxel against mouse melanoma cells and human lung cancer cells in vitro. It was not observed the structure-activity relationship and the specificity of antiproliferative activity against the cancer cell lines among compounds 1-3. More investigations about biological activities of 1-3 and other small organic molecules in P. linteus such as 4 are currently in progress.
Experimental
General Methods Optical rotation was measured with a JASCO P-1020 spectrometer. IR and UV spectra were measured with a JASCO FT-IR 4100 spectrometer and JASCO V-530 spectrometer, respectively. ESI-FT-IR-MS spectra were obtained using a Bruker Apex III, and 1 H-and 13 C-NMR spectra were acquired with a JEOL ECA-500 spectrometer. NMR spectra were recorded in pyridine-d 5 . The absorbance in MTT assay were measured with a Beckman-Coulter DTX-880 multimode plate reader.
Fungal Material Dried and powdered fruit bodies of wild P. linteus collected in China was supplied from Nihon Shoyaku Co., Ltd., Tokyo, Japan, in 2003. The voucher specimen is deposited in Laboratory of Pharmacognosy, College of Pharmacy, Kinjo Gakuin University.
Extraction and Isolaion Two 70 g portion of dried and powdered P. linteus natural fruit body (total 140 g) was extracted with hot MeOH (500 ml, 3ϫ3 h), and the solvent was removed to give the MeOH extract (5. 
